U.S. Consumer Product Safety Commission Warns of Suffocation Risk From 'Baby Loungers'
By Physician’s Briefing Staff HealthDay Reporter
FRIDAY, Dec. 29, 2023 -- The U.S. Consumer Product Safety Commission is sounding the alarm on a popular infant lounger that violates U.S. safety standards because it poses a fall hazard and suffocation risk to infants.
Though a notice of violation has been issued to the seller, Poetint002 of China, the company has not agreed to recall the loungers or offer consumers a remedy, the CPSC said in a news release.
The CPSC said the loungers fail to meet safety requirements because they lack a stand, creating an unsafe sleeping environment for babies. They also fall short of rules for marking, labeling, and instructions.
Consumers should stop using "Baby Loungers" immediately, the CPSC said, and consumers should unzip and take the products apart, cut up the lounger cover, sleeping pad, and side bumpers, and throw them out. Consumers who bought "Baby Loungers" will receive the notice directly.
Among other issues, the packaging lacks a tracking label with the date of manufacture. That is required for durable children's products, the CPSC said. The loungers were sold on Amazon.com and other online sites.
Those evaluated by the CPSC are oval in shape and were sold in fabric that is gray on the outside and white on the inside with animals such as lions, moose, and giraffes printed inside the lounger. A small pillow with similar imagery is included. CPSC said the products have a red tag with three rectangular symbols. A white label on the packaging identifies the products as "Baby Loungers."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
NT-proBNP, IL-1RL Can Identify High-Risk Congenital Heart Disease in Neonates
MONDAY, June 24, 2024 -- Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital heart disease (CHD) in newborns...
Maternal Distress Tied to Changes in Brain Growth of Offspring
FRIDAY, June 21, 2024 -- Regional neonatal brain volumes are associated with elevated maternal psychological distress, according to a study published online June 20 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.